Aurinia Pharmaceuticals to Release Third Quarter 2019 Financial Results on November 14, 2019 Nov 6, 2019
Aurinia Announces Initiation of Patient Dosing in Phase 2/3 AUDREY™ Clinical Trial for Dry Eye Syndrome Oct 31, 2019
Aurinia Reports Last Patient Study Visit in Aurora Phase 3 Lupus Nephritis Study and Provides Update on ATM Facility Oct 16, 2019
Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference Sep 6, 2019
Aurinia Pharmaceuticals to Release Second Quarter 2019 Financial Results on August 6, 2019 Aug 1, 2019
